[HTML][HTML] Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data
G Prajapati, A Das, Y Sun, E Fonseca - Clinical Therapeutics, 2023 - Elsevier
Purpose Molnupiravir is an oral antiviral agent authorized for emergency use to treat mild to
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data.
G Prajapati, A Das, Y Sun, E Fonseca - Clinical Therapeutics, 2023 - europepmc.org
Purpose Molnupiravir is an oral antiviral agent authorized for emergency use to treat mild to
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
[HTML][HTML] Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data
G Prajapati, A Das, Y Sun… - Clinical Therapeutics, 2023 - clinicaltherapeutics.com
Purpose Molnupiravir is an oral antiviral agent authorized for emergency use to treat mild to
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data
G Prajapati, A Das, Y Sun… - Clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Molnupiravir is an oral antiviral agent authorized for emergency use to treat mild to
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …